Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4H9E5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 170 | 172 | PF00675 | 0.564 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.586 |
CLV_PCSK_KEX2_1 | 140 | 142 | PF00082 | 0.632 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.586 |
CLV_PCSK_KEX2_1 | 86 | 88 | PF00082 | 0.576 |
CLV_PCSK_PC1ET2_1 | 140 | 142 | PF00082 | 0.632 |
CLV_PCSK_PC1ET2_1 | 86 | 88 | PF00082 | 0.601 |
CLV_PCSK_SKI1_1 | 4 | 8 | PF00082 | 0.639 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.594 |
DEG_SCF_FBW7_1 | 192 | 198 | PF00400 | 0.616 |
DEG_SPOP_SBC_1 | 195 | 199 | PF00917 | 0.507 |
DOC_CKS1_1 | 192 | 197 | PF01111 | 0.620 |
DOC_CKS1_1 | 48 | 53 | PF01111 | 0.530 |
DOC_PP4_FxxP_1 | 48 | 51 | PF00568 | 0.533 |
DOC_USP7_MATH_1 | 155 | 159 | PF00917 | 0.425 |
DOC_USP7_MATH_1 | 195 | 199 | PF00917 | 0.624 |
DOC_WW_Pin1_4 | 111 | 116 | PF00397 | 0.615 |
DOC_WW_Pin1_4 | 191 | 196 | PF00397 | 0.619 |
DOC_WW_Pin1_4 | 47 | 52 | PF00397 | 0.540 |
LIG_BRCT_BRCA1_1 | 157 | 161 | PF00533 | 0.606 |
LIG_FHA_1 | 62 | 68 | PF00498 | 0.592 |
LIG_FHA_2 | 47 | 53 | PF00498 | 0.603 |
LIG_LIR_Apic_2 | 47 | 51 | PF02991 | 0.537 |
LIG_LIR_Gen_1 | 55 | 63 | PF02991 | 0.550 |
LIG_LIR_Nem_3 | 55 | 60 | PF02991 | 0.557 |
LIG_SH2_STAT5 | 162 | 165 | PF00017 | 0.593 |
LIG_SH2_STAT5 | 181 | 184 | PF00017 | 0.433 |
LIG_SH3_3 | 151 | 157 | PF00018 | 0.687 |
LIG_SH3_3 | 189 | 195 | PF00018 | 0.544 |
LIG_TRAF2_1 | 126 | 129 | PF00917 | 0.379 |
MOD_CDK_SPK_2 | 191 | 196 | PF00069 | 0.463 |
MOD_CDK_SPxxK_3 | 111 | 118 | PF00069 | 0.601 |
MOD_CK1_1 | 89 | 95 | PF00069 | 0.656 |
MOD_CK2_1 | 46 | 52 | PF00069 | 0.588 |
MOD_CK2_1 | 73 | 79 | PF00069 | 0.666 |
MOD_GlcNHglycan | 88 | 91 | PF01048 | 0.632 |
MOD_GlcNHglycan | 9 | 12 | PF01048 | 0.619 |
MOD_GSK3_1 | 187 | 194 | PF00069 | 0.629 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.549 |
MOD_GSK3_1 | 82 | 89 | PF00069 | 0.415 |
MOD_N-GLC_1 | 111 | 116 | PF02516 | 0.582 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.612 |
MOD_PIKK_1 | 156 | 162 | PF00454 | 0.613 |
MOD_PKA_1 | 86 | 92 | PF00069 | 0.564 |
MOD_PKA_2 | 165 | 171 | PF00069 | 0.415 |
MOD_PKA_2 | 86 | 92 | PF00069 | 0.492 |
MOD_Plk_4 | 73 | 79 | PF00069 | 0.665 |
MOD_ProDKin_1 | 111 | 117 | PF00069 | 0.604 |
MOD_ProDKin_1 | 191 | 197 | PF00069 | 0.624 |
MOD_ProDKin_1 | 47 | 53 | PF00069 | 0.549 |
MOD_SUMO_rev_2 | 184 | 193 | PF00179 | 0.444 |
TRG_ENDOCYTIC_2 | 45 | 48 | PF00928 | 0.470 |
TRG_ER_diArg_1 | 2 | 4 | PF00400 | 0.591 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PC40 | Leptomonas seymouri | 65% | 100% |
A0A0S4JE60 | Bodo saltans | 31% | 100% |
A0A1X0P7T6 | Trypanosomatidae | 36% | 100% |
A0A3Q8I9X5 | Leishmania donovani | 83% | 100% |
A4HXR6 | Leishmania infantum | 82% | 100% |
D0A048 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 70% |
E9ARH8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
Q4QE01 | Leishmania major | 83% | 100% |